VOSOL 3 %
PROPYLENE GLYCOL DIACETATE : 3 % ACETIC ACID : 2 % BENZETHONIUM CHLORIDE : 0.02 % · DIN 00355046 · CARTER-HORNER CORP.
Health Canada status: CANCELLED POST MARKET
What is VOSOL?
VOSOL 3 % contains PROPYLENE GLYCOL DIACETATE : 3 % ACETIC ACID : 2 % BENZETHONIUM CHLORIDE : 0.02 %. It is listed in the Health Canada Drug Product Database under DIN 00355046, held by CARTER-HORNER CORP., supplied as LIQUID for OTIC administration. Health Canada currently lists it as cancelled post market, status dated 19-Aug-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00355046 |
|---|---|
| Brand name | VOSOL |
| Generic / active ingredient | PROPYLENE GLYCOL DIACETATE : 3 % ACETIC ACID : 2 % BENZETHONIUM CHLORIDE : 0.02 % |
| Manufacturer | CARTER-HORNER CORP. |
| Strength | 3 % |
| Dosage form | LIQUID |
| Route of administration | OTIC |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S02AA30 ANTIINFECTIVES, COMBINATIONS |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 19-Aug-2003 |
| Original market date | 1978-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S02AA30 ANTIINFECTIVES, COMBINATIONS. 1 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| POLYSPORIN PLUS PAIN RELIEF EAR DROPS | 10000 UNIT | DROPS | JOHNSON & JOHNSON INC | MARKETED | DIN 02239155 |
| ANTIBIOTIC EAR DROPS | 10000 UNIT | DROPS | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02458705 |
| BURO-SOL OTIC SOLUTION | 0.03 % | SOLUTION | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 00674222 |
| LIDOMYXIN | 10000 UNIT | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 00874949 |
| LIDOSPORIN EAR DROPS | 10000 UNIT | DROPS | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 00068454 |
| STAR-OTIC SOLUTION | 10 % | SOLUTION | STELLAR PHARMACAL CORP | CANCELLED POST MARKET | DIN 00852341 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.